MarketInOut Stock Screener Log In | Sign Up
 

Rocket Pharmaceuticals Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Rocket Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization247.54 mln
Float104 mln
Earnings Date11/05/2026

Piotroski F-Score

2 / 9
Weak

1-Year Forecast

8.58
Transformational upside

Relative Strength

23 / 100
Significantly lagging

Debt / Equity

0.07
Debt-free

ROE

-5.56
Negative

ROA

-4.72
Negative

Business Description

Rocket Pharmaceuticals is a late-stage biotechnology company based in Cranbury, New Jersey, focused on developing gene therapies to treat rare and life-threatening diseases. The company runs multiple treatment programs targeting serious heart conditions, immune system disorders, and blood diseases, using two distinct gene delivery approaches. Several of its therapies are already in clinical trials, while others are in earlier stages of research. Rocket works alongside leading academic and research institutions and holds licensing agreements that support the advancement of its pipeline.

Key Fundamentals

EPS-0.17
ROE-5.56
ROIC-128
ROA-4.72
Interest Cover-40.53
EBITDA, mln2.97
EV / EBITDA16.12
EV / EBIT-7.10

Quote Details

Last 2.29
Change -0.02 (-0.87%)
Open 2.27
Volume 1,598,568
Turnover 3,660,721
Average Volume 2,232,083

Financial Ratios

Leverage Ratio1.15
Current Ratio9.25
Price / Book0.78
Price / Tangible Book0.95
Debt / Equity0.07

Financial Strength

Piotroski F-Score 2 / 9
1-Year Target Price8.58
Short Ratio8.45
Short % of Float16.80

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.05% 88 / 100   
1 Month -14.87% 23 / 100   
2 Months -33.24% 15 / 100   
6 Months -34.94% 19 / 100   
1 Year -39.74% 22 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog